TY - JOUR
T1 - Erratum to
T2 - Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity (Nature, (2017), 551, 7680, (340-345), 10.1038/nature24302)
AU - Shalapour, Shabnam
AU - Lin, Xue Jia
AU - Bastian, Ingmar N.
AU - Brain, John
AU - Burt, Alastair D.
AU - Aksenov, Alexander A.
AU - Vrbanac, Alison F.
AU - Li, Weihua
AU - Perkins, Andres
AU - Matsutani, Takaji
AU - Zhong, Zhenyu
AU - Dhar, Debanjan
AU - Navas-Molina, Jose A.
AU - Xu, Jun
AU - Loomba, Rohit
AU - Downes, Michael
AU - Yu, Ruth T.
AU - Evans, Ronald M.
AU - Dorrestein, Pieter C.
AU - Knight, Rob
AU - Benner, Christopher
AU - Anstee, Quentin M.
AU - Karin, Michael
N1 - Publisher Copyright:
© 2018, Macmillan Publishers Ltd., part of Springer Nature.
PY - 2018/9/6
Y1 - 2018/9/6
N2 - In this Article, the sentence: “After 7 months of HFD, MUP-uPA mice developed HCC15, which contained numerous (usually 50–100 per tumour) non-recurrent coding mutations in pathways that are mutated in human HCC (Fig. 2d and Extended Data Fig. 6a).”, should have read: “After 7 months of HFD, MUP-uPA mice developed HCC15, which contained numerous (usually 50–100 per tumour) non-recurrent mutations in pathways that are mutated in human HCC (Fig. 2d and Extended Data Fig. 6a).”. This has been corrected online. In Extended Data Fig. 6a and b, which show the number of point mutations identified per sample and the mutational signatures, all sequence variants (including non-coding mutations) are shown. Fig. 2d also presents all variants compared to human mutations. In the Supplementary Information to this Amendment, we now provide the comparisons of all variants and coding variants to human mutations.
AB - In this Article, the sentence: “After 7 months of HFD, MUP-uPA mice developed HCC15, which contained numerous (usually 50–100 per tumour) non-recurrent coding mutations in pathways that are mutated in human HCC (Fig. 2d and Extended Data Fig. 6a).”, should have read: “After 7 months of HFD, MUP-uPA mice developed HCC15, which contained numerous (usually 50–100 per tumour) non-recurrent mutations in pathways that are mutated in human HCC (Fig. 2d and Extended Data Fig. 6a).”. This has been corrected online. In Extended Data Fig. 6a and b, which show the number of point mutations identified per sample and the mutational signatures, all sequence variants (including non-coding mutations) are shown. Fig. 2d also presents all variants compared to human mutations. In the Supplementary Information to this Amendment, we now provide the comparisons of all variants and coding variants to human mutations.
UR - http://www.scopus.com/inward/record.url?scp=85052994009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052994009&partnerID=8YFLogxK
U2 - 10.1038/s41586-018-0304-y
DO - 10.1038/s41586-018-0304-y
M3 - Comment/debate
C2 - 29973714
AN - SCOPUS:85052994009
SN - 0028-0836
VL - 561
SP - E1
JO - Nature
JF - Nature
IS - 7721
ER -